Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair loss in two ferrets was caused by ovarian tissue tumors, not adrenal issues.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Lifestyle changes and medical treatments can help manage infertility in women with PCOS.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Hirsutism in women often indicates health issues like polycystic ovarian syndrome and is treated with lifestyle changes, medication, and cosmetic measures.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Early detection and comprehensive care improve long-term health in PCOS.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

Women with PCOS often face menstrual issues, weight gain, and stress, affecting their quality of life.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Vorasidenib can cause unusual hair growth.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.